[1]
E. Vashakidze, T. Megrelishvili, I. Mikadze, E. Pachkoria, and M. Jangavadze, “TREATMENT WITH BARICITINIB INMODERATE AND SEVERE COVID-19 PATIENTS”, CSW, vol. 55, pp. 69–70, Feb. 2021.